Internal Medicine, Hematology · Wilkes Barre, PA
NPI
1750554986
Since 2008
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1000 E Mountain Blvd
Wilkes Barre, PA, 18711
Phone (570) 820-6150
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
707 services
Medicare patients, 2024
321
Average age 72
Drug cost, 2024
$7.0M
2,061 prescriptions
Company payments, 2025
$138
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James O Brady was code 99214 (office e&m - established), 539 times for 251 patients. In total James O Brady billed 707 services in 17 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 539 | 251 | $66.88 | $36K |
| 99222 Hospital E&M - Initial | Facility | 30 | 30 | $95.81 | $2,874 |
| 99205 Office E&M - New | Facility | 16 | 16 | $129.04 | $2,065 |
| 99215 Office E&M - Established | Facility | 16 | 15 | $108.55 | $1,737 |
| 99221 Hospital E&M - Initial | Facility | 16 | 15 | $61.38 | $982 |
| 99214 Office E&M - Established | Office | 15 | 14 | $96.58 | $1,449 |
By year: 2022 $44K for 636 services; 2023 $49K for 703 services; 2024 $49K for 707 services.
Medicare prescription drug claims, 2024
In 2024, the drug James O Brady prescribed most often to Medicare patients was Acyclovir, with 168 prescriptions and refills. In total James O Brady wrote 2,061 Medicare prescriptions that cost $7.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 168 | 313 | 46 | $2,689 |
| Allopurinol Generic | 166 | 292 | 46 | $1,750 |
| Famotidine Generic | 99 | 172 | 35 | $996 |
| Eliquis Apixaban | 95 | 161 | 26 | $90K |
| Hydroxyurea Generic | 82 | 158 | 17 | $1,711 |
| Imbruvica Ibrutinib | 66 | 66 | Under 11 | $1.1M |
| Venclexta Venetoclax | 65 | 66 | Under 11 | $653K |
| Potassium Chloride Generic | 56 | 111 | 18 | $1,220 |
| Lenalidomide Generic | 55 | 55 | 12 | $634K |
| Imatinib Mesylate Generic | 53 | 53 | Under 11 | $7,615 |
| Revlimid Lenalidomide | 51 | 51 | 12 | $864K |
| Prednisone Generic | 48 | 73 | 20 | $388 |
| Calquence Acalabrutinib Maleate | 46 | 46 | Under 11 | $528K |
| Brukinsa Zanubrutinib | 42 | 42 | Under 11 | $550K |
| Ondansetron Hcl Generic | 41 | 41 | 17 | $542 |
Brand drugs: - claims; generic drugs: 1,478 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James O Brady $138 ($138 in general payments such as food, travel and fees) from 3 companies. The largest payer was Noah Medical Corporation with $83.84.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.